Newcastle University

Roles and responsibilities

Honorary Consultant in Paediatric and Adolescent Oncology

Newcastle upon Tyne Hospitals NHS Foundation Trust 

• Windebank K, Morgan S. Starting an Adolescent Cancer Unit: Why Does It Take so Long?. Pediatric Blood & Cancer 2004, 42(3), 241–248.
• Slatter MA, Angus B, Windebank K, Taylor A, Meaney C, Lester T, Norbury G, Hambleton S, Abinun M, Flood TJ, Cant AJ, Gennery AR. Polymorphous lymphoproliferative disorder with Hodgkin-like features in common gamma-chain-deficient severe combined immunodeficiency. Journal of Allergy and Clinical Immunology 2011. 360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA: MOSBY-ELSEVIER, 127(2), 533-535.
• Salotti J, Nanduri V, Pearce MS, Parker L, Lynn RM, Windebank KP. Incidence and clinical features of Langerhans cell histiocytosis in the UK and Ireland. Archives of Disease in Childhood 2009, 94(5), 376-380.
• Windebank K, Nanduri V. Langerhans Cell Histiocytosis. Archives of Disease in Childhood 2009, 99(11), 904-908.
• Windebank KP, Walwyn T, Kirk R, Parry G, Hasan A, Bown N, Wilkins B. Post Cardiac Transplantation Lymphoproliferative Disorder Presenting as t(8;14) Burkitt Leukaemia/Lymphoma Treated With Low Intensity Chemotherapy and Rituximab. Pediatric Blood & Cancer 2009, 53(3), 392-396.
• Feltbower RG, McNally RJQ, Kinsey SE, Lewis IJ, Picton SV, Proctor SJ, Richards M, Shenton G, Stark DP, Skinner R, Vormoor J, Windebank KP, McKinney PA. The epidemiology of leukaemia and lymphoma in children and young adults from the north of England, 1990-2002. European Journal of Cancer 2009, 45(3), 420-427.
• Windebank KP. Advances in the management of histiocytic disorders. Paediatrics and Child Health 2008, 18(3), 129-135.
• Windebank KP, Spinetta JJ. Do as I say or die: Compliance in adolescents with cancer. Pediatric Blood & Cancer 2008, 50(S5), 1099-1100.
• Minkov M, Steiner M, Pötschger U, Aricò M, Braier J, Donadieu J, Grois N, Henter J-I, Janka G, McClain K, Weitzman S, Windebank KP, Ladisch S, Gadner H, International LCH Study Group. Reactivations in multisystem Langerhans cell histiocytosis: data of the international LCH registry. Journal of Pediatrics 2008, 153(5), 700-705.
• Jones GL, Taylor PRA, Windebank KP, Hoye NA, Lucraft HH, Wood K, Angus B, Proctor SJ. Outcome of a risk-related therapeutic strategy used prospectively in a population-based study of Hodgkin's lymphoma in adolescents. British Journal of Cancer 2007, 97(1), 29-36.
• Reynolds BC, Windebank KP, Leonard RCF, Wallace WHB. A Comparison of Self-Reported Satisfaction Between Adolescents Treated in a "Teenage" Unit With Those Treated in Adult or Paediatric Units. Pediatric Blood Cancer 2005, 44(3), 259-263.
• Pearce, M. S., Parker, L., Windebank, K. P., Cotterill, S. J., Craft, A. W. Cancer in adolescents and young adults aged 15-24 years: A report from the North of England Young Person's Malignant Disease Registry, UK. Pediatric Blood and Cancer 2005, 45(5), 687-693.
• Bradshaw EJ, Wood KM, Hodgkinson P, Lucraft H, Windebank KP. Follicular dendritic cell tumour in a 9-year-old child. Pediatric Blood and Cancer 2005, 45(5), 725-727.
• Windebank KP. Hodgkin's Disease and Adolescents. In: Eden, T.O.B., Barr, R.D., Bleyer, A., Whiteson, M, ed. Cancer and the Adolescent. Malden, Massachusetts, USA: Blackwell, 2005, pp.83-95.
• McGovern N, Bigley V, Allen C, Haniffa M, Wang XN, Dickinson R, Pagan S, Windebank K, McClain K, Ginhoux F, Merad M, Collin M. Human Langerin plus dendritic cells are independent of epithelial Langerhans cells; a novel perspective on Langerhans cell histiocytosis. In: Immunology: Annual Congress of the British Society for Immunology. 2011, Liverpool, UK: Wiley-Blackwell Publishing Ltd.
• Windebank KP. Hodgkin's disease and adolescents: the lost tribe?. In: 3rd International Conference on Cancer and the Adolescent. 2005, London, UK: Wiley-Blackwell.